• linkedin
  • Increase Font
  • Sharebar

    First direct-to-consumer test for breast cancer risk hits market


    FDA approved the first direct-to-consumer (DTC) test for 3 specific BRCA1/BRCA2 breast cancer gene mutations.

    The Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected Variants), from 23andme, tests for 3 specific BRCA1/BRCA2 breast cancer gene mutations that are most common in people of Ashkenazi (Eastern European) Jewish descent. The 3 mutations, however, are not the most common BRCA1/BRCA2 mutations in the general population, FDA said in a statement.

    Related: FDA approves first drug for breast cancer with BRCA gene

    In January, FDA also approved the first drug to treat certain patients with metastatic breast cancer who have a BRCA gene mutation. FDA expanded the approved use of olaparib (Lynparza, AstraZeneca and Merck) beyond ovarian cancer, to include the treatment of patients with certain types of breast cancer that have metastasized and whose tumors have a specific inherited BRCA genetic mutation.

    Meanwhile, the GHR Report only detects 3 out of more than 1,000 known BRCA mutations. “This means a negative result does not rule out the possibility that an individual carries other BRCA mutations that increase cancer risk,” FDA said.

    Related: Top 3 new cancer drugs

    “This test provides information to certain individuals who may be at increased breast, ovarian or prostate cancer risk and who might not otherwise get genetic screening, and is a step forward in the availability of DTC genetic tests. But it has a lot of caveats,” said Donald St. Pierre, acting director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health, in the statement. “While the detection of a BRCA mutation on this test does indicate an increased risk, only a small percentage of Americans carry one of these three mutations and most BRCA mutations that increase an individual’s risk are not detected by this test. The test should not be used as a substitute for seeing your doctor for cancer screenings or counseling on genetic and lifestyle factors that can increase or decrease cancer risk.”

    The test analyzes DNA collected from a self-collected saliva sample, and the report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer.

    “Consumers and health care professionals should not use the test results to determine any treatments, including anti-hormone therapies and prophylactic removal of the breasts or ovaries. Such decisions require confirmatory testing and genetic counseling, “ FDA said. “The use of the test carries significant risks if individuals use the test results without consulting a physician or genetic counselor.”

    The three BRCA1/BRCA2 hereditary mutations detected by the test are present in about 2% of Ashkenazi Jewish women, according to a National Cancer Institute study, but rarely occur in other ethnic populations, according to FDA.

    Read more: 3 new FDA drug approvals

    1 Comment

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • [email protected]
      After my 3rd pulmonary embolism in 2003, I was diagnosed with pulmonary fibrosis and I read that people usually die within 5 years. My specialist has me on blood thinners, prednisone and other steroids that I inhale daily. October 2006 I decided to go with natural treatment and was introduced to Green House Herbal Clinic natural organic idiopathic pulmonary fibrosis Herbal formula, i had a total decline of symptoms with this pulmonary fibrosis Herbal formula treatment. The infections, shortness of breath, fatigue, dry cough and other symptoms has subsided. Somehow, the herbs managed to keep me alive for 13 years.Visit Green House Herbal Clinic official website w ww.greenhouseherbalclinic .com or email [email protected] greenhouseherbalclinic. com. I have had great improvement with my over all respiration with this product and i breath very much easier, i can never be thankful enough to nature